Despite lhe critical role of the Langcrhans cells in lhe induction of contact hypersensitivity reactions, non-Langerhans aniigen-presentirg celis in already sensitized individuals may play a role in the elicilalion phase of a contact hypersensilivity reaction. Following epictitaneous challenge with antigens, lhe number of CDl ' DR ' epidermal Langerhans cells increased in a time-dependent way and. concomiiantly. CDl "OKM5 ' DR ' epidermal non-Langerhans celis appeared. In parallel with this, the capacity of epidermal cells to preseni both alloantigens and auto/nominal aniigens increased, and 4 days after initiation of the contact hypersensitivity reactions 33 53'^J of the epidermal aniigen-prescnting capacity was due to CDi nonLangerhans antigen-presenting ceils. Thus, contact hypersensitivity skin reactions are accompanied by the appearance of non-Langeriians antigen-presenting cells capable of presenting both alloantigens and auto/nominai antigens.
In normal human epidermis the Langerhans cell is the only cell type capable of presenting antigens to T lymphocytes, thus eliciting T-ce!l activation [7. 8, 29] . Human epidermal Langerhans cells express CDl [12] and major liisiocompatibility complex (MHC) class II molecules [16. 22] . Tlic Langerhans cells are critical for lhe induction of delayed-type hypersensilivity reactions in mice [21. 31, 32] . Thus, sensitizalion through murine skin depleted of Langerhans cells results in the induction of antigen-specific tolerance rather than a contact hypersensitivity reaction [24. 30. 31. 32] , While the Langerhans cells are critical for the induction ofthe immune response in contact hypersensitivity reactions. non-Langerhans antigen-presenting cells may play a role in the effector phase ofthe Immune response. This is supported by the findings in sensitized humans which demonstrate that irradiation of the skin with up lo four minimal erythema doses |MED) of UVB. a dose that normally efliciently abrogates the function of epidermal Langerhans cells, had no effect on subscqueni challenge with contact allergens [27] . This coLild be the result of rapid recovery of functional Langcrhans cell activity. However, since UVB irradiation induces the appearance of CDl DR • epidermal non-Langerhans cells [1-3. 5. 10. 11] , this cell type may, in addition to the Langerhans cells, be capable of presenting antigens to primed T cells, eliciting Tcell activation. This observation prompted us to study the function and type of epidermal antigenpresenting cells present in the skin al various time points following initiation of allergic skin reactions. It was found ihat CDI OKM5'DRê pidermal non-Langerhans antigen-presenting cells appear during hypersensitivity reactions and were in two experiments responsible for up to . 13 and SV'A, ofthe tola! epidermal antigen-presenting capacity. Whether these cells function to up-or down-regulate the immune function response is unknown.
MATERIALS AND METHODS
Pativni.s. Nine paticnis with contact allergy verified by patch test participated in the study after giving informed consent. Each patient was challenged with serial dilutiotis of relevant haplen in order to determine a concentration of hapten which induced erthetna and infiltration but not vesiculation (i.e, -I-to -^ -I-reactions). The haptens used were primin. nickel sulphate, sodium dichromate. cthylene diaminedihydrochioride, yarrow, and clioqtjinoi. Twelve-millimetre Finn chambers were used Tor patch testing. Four patches with haptens in petrolatum were applied on the volar forearmat least 5cmapart. at I. .1.4. and 7 days prior to investigation. In addition, a chamber filled with petrolatum was used as vehicle control and applied for 48 h 4 days prior to the study. All patches were removed after 24 or 48 h.
Preparation of epidermal eell .••u.spen.sions. Suction blister-derived epidermal cells were obtained from unchallenged areas and Trom siies challenged with vehicle (petrolatum) or hapten in petrolatum. Epidermal sheets were floated deniiiil side down on 0.25% trypsin (U,S. Biochemical Corp,, Cleveland. Ohio, USA) in Dulbecco's phosphate-buffered saline (PBS) for 40 miti al 37 C. Trypsinized epidermal sheets were transferred to 0.025'Wi DNAse (Sigma. St Louis. Mo,, USA) in Dulbecco's PBS, teased into a cell suspension, and were filtered through nylon gauze to achieve a singie-cell suspension. Fetal bovine serum (FBS) was added to inactivate the Irypsin, and the eells were washed three times in PBS containing 10'^., FBS. Epidermal cells were then resuspended in RPMI 1640 wilh added antibiotics, glutamine. and 10"" human AB serum from non-transfused male donors. Cell viability (trypan blue exclusion) was monitored in haemocytometers and was more than ^5"^,.. Epidermal eetl'surfatc membrane slaining. Cell suspensions were stained simultaneously with biotin-conjugated anti-HLA-DR (Becton Dickinson. Sunnyvale, Calif,. USA) and either fluorescein isothiocyanate (FITC)-conjugated anti-HLet (CD45) (Becton Dickinson), OKr6 (CDl), OKM5 (Ortho Immunodiagnostics. Ruritan, NJ, USA), or the appropriate isotype controls for 45 min at 4 C, The cells were then washed three times in Dulbecco's PBS containing NaNi and bovine serum albumin (BSA), and incubated with streptavidin-conjugated Texas red (Bethesda Research Ubs. Bethesda. Md. USA) for .^0 mm at 4 C, The cells were washed, and propidium iodide was added to monitor viability. A total of \0i)0 ceils was counted using a Zeiss microscope equipped wilh epifluorescence. The resull was expressed as the percenlage ±SEM of labelled viable cells (negative for propidium iodide) oT total cell count, A three-step staining procedure was then applied, as previously described |2lj. The eel! suspensions were briefly incubated with unconjugated monoclonal antibody for 45 min at 4 C, A second incubation was performed using human serumabsorbed rhodamine-conjugated rabbit anli-mouse IgG (Dacopalts. Copenhagen. Denmark) diluted in PBS containing 10% vol/vot human AB serum. Finally, a third incubation was perfonned using normal mouse sera (in excess to occupy residual anti-IgG sites) and FITC-conjugated monoclonal antibody.
Depletion oJ leucocytes contained within lhe epidermal cell su.spension. Leucocytes were depleted from the epidermal cell suspensions using magnetic beads coated with anti-mouse IgG (Dynal As. Skoyen, Norway). Epidermal cells pretrealed with anti-HLA-DR. antiLeu6 (Becton Dickinson), or a combination ofthe two antibodies were incubated for .10 min at 4 C. on a rotating rack; cells bound to beads were removed by exposure to a magnet, and lhe cell subsets remaining in suspension were harvested.
Preparation of peripheral hlood mononucleur cells.
Allogeneic or autologous peripheral blood mononuelear cells (MNC) were isolated from heparinized venous blood by Ficoll Hypaque density-gradient eentrifugation, MNC al the interface were collected. washed three times, and restispended in RPMI 1640 with added antibiotics, glutamine. and lO"';, htmian AB serum, isolation of T celh. Human peripheral blood MNC were incubated on plastic for I h at 37 C. The maerophage-depleted non-phislic adherent MNC were then rosetted with I"/.. 2-aniinoethyl-isothiouronium bromide hydro bromide-trealed sheep red blood eells. A second Ficoll Hypaquedensity-gradientcentrifugation was performed to obtain non-rosetting B and null cells at the interface (E ) and rosetted T lymphocytes from the pellet (E '). The E ' -ceil fraeiion contained more than 95"ii T lymphocytes as determined by staining wilh fluoresceinated anti-Leu 1 (CD.*)) (Beeton Dickinson. Mountain View. Calif.. USA). Tbe Tcells were further depleted of antigen-presenting ceils by complement lysis of HLA-DR' leucocytes. 
Proliferalive response of T lymphocytes lo

RESULTS
Epidermal celts from contact hypersensitivity reactions contain increased number.^ of CDl ^ DR* iton-Langerhans cells atul CDl 0KM5' DR' non-Langerhans cells
Occlusion of the skin with petrolatum for 48 h induced the appearance of an increased number . n = 5) to a maximum at day 7 (mean 3.7± 1.4%. /i = 5). Concomitantly, the number or CDl DR'/OKM5'DR^ nonLangerhans epidermal cells also increased from the vehicle control baseline (mean 0%-l-0, n = 5) to a maximum at day 7 (mean 1.3+0.6%, n = 5) (Fig. 1) . The number of CDI DR' epidermal cells was equal to the number of OKM5'DR' epidermal cells, and both the OKM5 ' epidermal cells and the DR' epidermal cells coexpressed HLel.
indicating that all CDl DRV R*^ epidermal cells were bone marrowderived leucocytes and that no DR' or OKM5* keratinocytes were present. These data also indicate that CD1"DR' epidermal cells coexpress OKM5. 
autologous T cells (F"ig. 2.). Similar results were obtained in another patient using nickel sulphate.
Results from the patient challenged with nickel sulphate on day 4 are shown in Fig. 5 .
Contact hypersensitivity reactions result in an increased capacity of epidermal cells to activate allogeneic T cells
The increased capacity of hapten-challenged epidermal cells to activate autoiogous T cells could be the result ofeither an increased number of antigen-presenting cells or increasing presentation of processed haplen to the primed autologous Tcells. To determine whether the challenged skin actually demonstrated an increased functional antigen-presenting eapaeity, allogeneic epidermal cell lymphoeyte reactions were performed since this reaction is not affected by the presence of nominal antigen.
Hapten-challenged epidermal cells in 5 out of 5 individuals tested demonstrated enhanced capacity to activate allogeneic T cells relative to vehicle-challenged epidermal cells (Table 1 and Fig, 3) . The mean percentage increases compared with vehicle-challenged control values at an epidermal cell concentration of 40,000 is shown in Table I (n = 5, P<0,05, Student's t test). The increase was seen in all patients tested indepen- ND. not determined. dent of the hapten used. However, the increase was less than when autologous T cells were used as responder cells. Furthermore, the allogeneic reaction peaked at day 3, whereas the autologous reaction was still increasing 7 days after hapten challenge.
Irrespective of these differences, hapten-challenged skin demonstrated increased capacity to present not only nominal and/or autoantigens but also alloantigens, and thus an increased function of antigen-presenting cells. 
The capacity of attergen-chattenged skin to activate T cetts is dependent on both CDl' DRL angerhans cells and CDl DR* antigenpresenting cells
The discovery of the presence of non-Langerhans DR' epidermal cells in hypersensitivity reactions raises the possibility that non-Langerhans antigen-presenting cells may participate in the epidermal antigen presentation during an allergic skin reaction. the epidermal antigen presentation capacity. In contrast, depletion of all DR' epidermal cells resulted in total abrogation of the epidermal alloantigen presentation capacity (AC-EC) (Fig.  4) . This was not the result of incomplete removal of CDP cells since depletion of CDl ^ eells contained within unchallenged (C-EC) or vehiclechallenged (OC-EC) epidermal cells totally abrogated the epidermal antigen-presenting function (Fig. 4) . Similar results were obtained when autologous responder T cells were used, indicating that CDl DR' non-Langerhans antigenpresenting cells can present hoth alloantigens and autologous/nominal antigetis (Fig. 5) . In two experiments 33 and 5yA, of the total antigenpresenting cell activity of 40.000 epidermal cells was provided by non-Langerhans antigen-presenting cells (Fig. 4) .
DISCUSSION
The Langerhans cell is the only known atitigenpresenting cell in normal human epldertnis, and its role as an antigen-processing cell in the induetion of positive itnmune responses to untigen introduced through the skin is well established [14, 21. 31, 32] . However, the epidermal cellular sources for antigen presentation in the induction phase of allergic contact dermatitis reactions are less clear. Irradiation of sensitized individuals in vivo with a single dose of UVB radiation sufficient to abrograte lhe function of Langerhans cells did not change the immune reactivity oTthe skin to subsequent ctiallenge with antigen [27] . This eould be explained by rapid recovery of epidermal Langerhans cells following the irradiation. However, normally more than I week is needed for recovery of epidermal Langerhans eells following in vivo UVB exposure [10] . Therefore, although the Langerhans eell is the critical antigen-presenting cell in the sensitization phase of the contact hypersensitivity response, epidermal non-Langerhans antigen-presenting cells could, in addition to Langerhans cells, play a role in the induction phase. In accordance with others we found an increased number of epidermal Langerhans cells following the contact hypersensitivity reactions [9. 13]. However, in addition to the increased number of Langerhans cells, a non-Langerhans antigen-presenting cell subtype appeared. These cells were distinct from the Langerhans cells in that they were smaller, non-dendritic, and they lacked the CDl determinant and expressed the blood monocyte antigen defined by the monocional antibody OKM5. The majority ofthe OKM5' epidermal ceils lacked expression of OKMl and therefore are analogous to 11 minor subpopulation (<5'X,) of OKMl 0KM5' blood monocytes which are uniquely capable of activating autoreactive immunoregulalory Tcells [25] which may be important for down-regulation of imtnunc responses [15, 20. 23, 28] . All CDI The function ofthe heterogeneous population of CDl DR ' non-Langerhans antigen-presenting cells in contact hypersensitivity skin reactions and irritant reactions [18] is unknown. They may function to enhance the ongoing immune response by presenting nominal antigen to primed T cells. However, they may also be analogous to the CDl OKM5'DR antigen-presenting cell subtype that appears in human skin in response to certain wavelengths of UV irradiation [I. 2. 3. 5. 10, 11]. This UV-induced antigen-presenting cell population activates suppressor T-cell pathways and tnay function to down-regtilate immune responses [2, 4] . Thus, the non-Langerhans antigen-presenting cells may represent a negative feedback mechanism down-regulating the inflammatory reaction in contact denrtatitis.
Whether these non-Langerhans cells belong to the monocyte or Langerhans cell lineage is unknown. In cutaneous T-cell lymphoma CDl OKM5'DR' non-Langerhans cells are present in the epidermis. However, these cells lack Birbeck granules [17] . Thus, the CD|-OKM5' epidermal cells may be precursors to Langerhans ceils and in the epidermal environment they may lose their OKM5 expression and gain CDI and Birbeck granules. However, they may also be distinct from the Langerhans cell lineage.
